Summary：**Alarm as Company Claiming Spy Tracking Hired to Investigate Havana Syndrome***Introduction* A con

referrerpolicy="no-referrer"
style="max-width:100%;height:auto;display:block;margin:0 auto;">

**Alarm as Company Claiming Spy Tracking Hired to Investigate Havana Syndrome**

*Introduction*
A controversial tech firm that once bragged it could locate CIA and NSA operatives through smartphone data has been tapped to join a federal task force probing the mysterious ailments known as Havana syndrome. Anomaly 6, the company behind the claim, says its proprietary phone‑tracking platform can pinpoint the movements of U.S. intelligence officials in real time. The decision to involve a vendor that markets itself as a spy‑watcher has raised eyebrows across Capitol Hill and the intelligence community, prompting questions about conflicts of interest, data privacy, and the scientific rigor of the investigation.

*Key Developments*
In early September, the Office of the Director of National Intelligence (ODNI) announced that Anomaly 6 would provide analytical support to the interagency Havana syndrome working group. The firm’s pitch highlighted its ability to correlate geolocation data from millions of devices with reported symptom clusters, allegedly revealing patterns that point to directed energy exposure. Critics note that the same marketing materials previously boasted that the technology could “track U.S. spies anywhere in the world,” a claim that prompted a Senate hearing last year over potential misuse. Despite those concerns, ODNI officials said the contract was awarded after a standard vetting process focused on technical capability, not promotional rhetoric.

*Industry Analysis*
The inclusion of a surveillance‑focused vendor in a health‑related investigation underscores a growing trend: government agencies are turning to commercial data‑analytics firms to tackle complex, poorly understood phenomena. While such partnerships can accelerate data processing and bring novel methodologies to bear, they also introduce risks. Privacy advocates warn that repurposing spy‑tracking tools for medical research could inadvertently expose personal information of civilians whose devices happen to be near affected personnel. Moreover, the scientific community remains skeptical about linking